Air-pollution-driven dysbiosis of the airway microbiome generates oxidative metabolites that raise local ROS, activate NF-κB signaling (elevating IL-17 and allied cytokines), and thereby sustain the type-2-skewed inflammatory milieu characteristic of asthma [64]. This evidence concerns the gene NFKB1 and asthma.